DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Feng K, Guo Y, Dai H. et al.
Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer.
Science China Life sciences 2016;
59: 468-479
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.